North America GMP Cytokines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (TNF, Interleukins, Growth Factors, Others); Application (Cell and Gene Therapy, Tissue-Engineered Products, Others) and Country
Market Introduction
Cytokines play a significant role in regulating innate and adaptive immunity, which enable cells of the immune system to communicate over short distances. The cytokine therapy to activate cancer patients' immune systems has been an essential parameter in the treatment. Moreover, some cytokines indirectly inhibit tumor growth by stimulating the cytotoxic activity of immune cells against tumor cells.
Get more information on this report :
Market Overview and Dynamics
The North America GMP cytokines market is expected to reach US$ 66.92 million by 2027 from US$ 35.49 million in 2019; it is estimated to grow at a CAGR of 8.3% from 2020 to 2027. The growth of the North America GMP cytokines market is attributed to key driving factors, such as increase in acceptance of cytokines for cancer and autoimmune therapies and potential contribution in stem cell therapy. However, high cost associated with GMP cytokines therapy is expected to obstruct the growth of the market to a certain extent during the forecast period.
Key Market Segments
Based on type, the North America GMP cytokines market is segmented into TNF, interleukins, growth factors, and others. The growth factors segment held the largest share of the market in 2019, whereas, the TNF segment is expected to register the highest CAGR in the market during the forecast period.
In terms of application, the North America GMP cytokines market is segmented into cell and gene therapy, tissue-engineered products, and others. The cell and gene therapy segment held the largest share of the market in 2019; however, the tissue-engineered products segment is anticipated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
A Few of the primary and secondary sources associated with this report on the North America GMP cytokines market are the Canadian Institutes of Health Research (CIHR), International Stem Cell Corporation (ISCO) and Centers for Disease Control and Prevention (CDC).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of the North America gmp cytokines market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the North America gmp cytokines market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America gmp cytokines market.
NORTH AMERICA GMP CYTOKINES SEGMENTATION
By Application
- Cell and Gene Therapy
- Tissue-Engineered Products
- Others
By Country
- US
- Canada
- Mexico
Company Profiles
- Miltenyi Biotec
- Sino Biological Inc.
- ABCAM
- PeproTech, Inc.
- Akron Biotech
- BIO-TECHNE CORPORATION
- CREATIVE BIOARRAY
- Proteintech Group, Inc.
- REPROCELL, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America GMP Cytokines Market – By Type
1.3.2 North America GMP Cytokines Market – By Application
1.3.3 North America GMP Cytokines market – By Country
2. GMP Cytokines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America GMP Cytokines – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Expert Opinions
5. GMP Cytokines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Acceptance of Cytokines for Cancer and Autoimmune Therapies
5.1.2 Potential Contribution in Stem Cell Therapy
5.2 Market Restraints
5.2.1 High Cost Associated with GMP Cytokines Therapy
5.3 Market Opportunities
5.3.1 Extensive Pipeline of Drug Candidates for Cytokines Therapeutics
5.4 Future Trends
5.4.1 Utilization of Cytokines as Biomarkers
5.5 Impact Analysis
6. GMP Cytokines Market – North America Analysis
6.1 North America GMP Cytokines Market Revenue Forecast and Analysis
7. GMP Cytokines Market Analysis – By Type
7.1 Overview
7.2 GMP Cytokines Market Revenue Share, by Type (2019 and 2027)
7.3 TNF
7.3.1 Overview
7.3.2 TNF: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Interleukin
7.4.1 Overview
7.4.2 Interleukin: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Growth Factor
7.5.1 Overview
7.5.2 Growth Factor: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
8. GMP Cytokines Market Analysis – By Application
8.1 Overview
8.2 GMP Cytokines Market Revenue Share, by Application (2019 and 2027)
8.3 Cell and Gene Therapy
8.3.1 Overview
8.3.2 Cell and Gene Therapy: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Tissue-Engineered Products
8.4.1 Overview
8.4.2 Tissue-Engineered Products: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
9. GMP Cytokines Market – North America Analysis
9.1 North America GMP Cytokines Market Revenue and Forecasts To 2027
9.1.1 North America GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.2 North America GMP Cytokines Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.3 North America GMP Cytokines Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.1.4 North America GMP Cytokines Market Revenue and Forecasts to 2027, By Country (%)
9.1.5 US GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.5.1 US GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.5.2 US GMP Cytokines Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.5.3 US GMP Cytokines Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.1.6 Canada GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 Canada GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 Canada GMP Cytokines Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.6.3 Canada GMP Cytokines Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.1.7 Mexico GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 Mexico GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Mexico GMP Cytokines Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.7.3 Mexico GMP Cytokines Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10. Impact of COVID-19 Pandemic on North America GMP Cytokines Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 Miltenyi Biotec
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Sino Biological Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 ABCAM
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 PeproTech, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Akron Biotech
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 BIO-TECHNE CORPORATION
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 CREATIVE BIOARRAY
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Proteintech Group, Inc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 REPROCELL, Inc.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. North America GMP Cytokines Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 2. North America GMP Cytokines Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 3. US GMP Cytokines Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 4. US GMP Cytokines Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 5. Canada GMP Cytokines Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 6. Canada GMP Cytokines Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 7. Mexico GMP Cytokines Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 8. Mexico GMP Cytokines Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 9. Glossary of Terms, GMP Cytokines Market
LIST OF FIGURES
Figure 1. GMP Cytokines Market Segmentation
Figure 2. GMP Cytokines Market Segmentation, By Region
Figure 3. GMP Cytokines Market Overview
Figure 4. TNF Segment by Type Segment Expected to Witness Rapid Growth
Figure 5. North America GMP Cytokines Market – Leading Country Markets (US$ Million)
Figure 6. North America PEST Analysis
Figure 7. GMP Cytokines Market Impact Analysis of Drivers and Restraints
Figure 8. North America GMP Cytokines Market – Revenue Forecast and Analysis – 2019- 2027
Figure 9. GMP Cytokines Market Revenue Share, by Type (2019 and 2027)
Figure 10. TNF: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Interleukin: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Growth Factor: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. GMP Cytokines Market Revenue Share, by Application (2019 and 2027)
Figure 15. Cell and Gene Therapy: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Tissue-Engineered Products: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. North America GMP Cytokines Market Revenue Overview, by Country, 2019 (US$ Mn)
Figure 19. North America GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America GMP Cytokines Market Revenue and Forecasts to 2027, By Country (%)
Figure 21. US GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Canada GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Mexico GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Impact of COVID-19 Pandemic in North America Country Markets
- Miltenyi Biotec
- Sino Biological Inc.
- ABCAM
- PeproTech, Inc.
- Akron Biotech
- BIO-TECHNE CORPORATION
- CREATIVE BIOARRAY
- Proteintech Group, Inc.
- REPROCELL, Inc.
- Determine prospective investment areas based on a detailed trend analysis of the North America gmp cytokines market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the North America gmp cytokines market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America gmp cytokines market.